Amy provides a full range of services to clients, including the preparation and prosecution of domestic and international patent applications, and post-grant review. A significant amount of her work involves conducting due diligence reviews for licensing or acquisition of worldwide patent portfolios, as well as negotiating and drafting the resulting agreements. Amy provides strategic guidance, including freedom-to-operate analyses, invalidity, and non-infringement opinions, as well as life-cycle management analyses, product portfolio reviews, and Abbreviated New Drug Application (ANDA) litigation support. In addition, she counsels clients on regulatory issues associated with research and development of pharmaceuticals, biologics, and medical devices.

Clients value Amy’s creative approach, which draws on her significant in-house experience and thinks forward into all the possible options available for protecting valuable drug developments. She provides a unique perspective, one focused on understanding the science behind an innovation and, more importantly, where the technology is headed in the future. Amy has the technical background to speak with scientists about their developments, but also considers input from other departments in the company to appreciate the commercial potential of the innovation and offer risk management strategies. Informed by time spent around the boardroom table with all stakeholders, Amy poses the questions other patent lawyers may not think to ask. This holistic approach means Amy finds patent solutions that are both grounded in science and serve a client’s broader business objectives.